Holdings of PROFUND VP BIOTECHNOLOGY
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 41.7M $ including 40.6M $ in equities, 97.3 %
- Positions
- 147 in 6 countries
- Top ten
- 13.3 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Apellis Pharmaceuticals Inc | 18,547 | 746.1K $ | 1.79 % |
| 2 | Alkermes PLC | 16,692 | 590.2K $ | 1.41 % |
| 3 | Madrigal Pharmaceuticals Inc | 1,074 | 562.2K $ | 1.35 % |
| 4 | TG Therapeutics Inc | 16,526 | 549K $ | 1.32 % |
| 5 | Insmed Inc | 3,325 | 543.7K $ | 1.30 % |
| 6 | Scholar Rock Holding Corp | 10,735 | 527.7K $ | 1.26 % |
| 7 | Apogee Therapeutics Inc | 6,207 | 522.4K $ | 1.25 % |
| 8 | Protagonist Therapeutics Inc | 4,805 | 506.4K $ | 1.21 % |
| 9 | Summit Therapeutics Inc | 26,625 | 504.8K $ | 1.21 % |
| 10 | United Therapeutics Corp | 851 | 504.6K $ | 1.21 % |
| 11 | Praxis Precision Medicines Inc | 1,561 | 502.9K $ | 1.21 % |
| 12 | Arrowhead Pharmaceuticals Inc | 7,978 | 500.2K $ | 1.20 % |
| 13 | Cogent Biosciences Inc | 12,848 | 494.5K $ | 1.18 % |
| 14 | Bridgebio Pharma Inc | 6,493 | 482.2K $ | 1.16 % |
| 15 | PTC Therapeutics Inc | 7,059 | 480.9K $ | 1.15 % |
| 16 | Cytokinetics Inc | 7,285 | 480.2K $ | 1.15 % |
| 17 | Alnylam Pharmaceuticals Inc | 1,447 | 478.8K $ | 1.15 % |
| 18 | Exelixis Inc | 11,103 | 476.2K $ | 1.14 % |
| 19 | Nuvalent Inc | 4,633 | 474.7K $ | 1.14 % |
| 20 | Kymera Therapeutics Inc | 5,686 | 473.6K $ | 1.13 % |
| 21 | CG oncology Inc | 6,986 | 472.8K $ | 1.13 % |
| 22 | Natera Inc | 2,358 | 471.6K $ | 1.13 % |
| 23 | Neurocrine Biosciences Inc | 3,578 | 471.4K $ | 1.13 % |
| 24 | Twist Bioscience Corp | 9,892 | 470.1K $ | 1.13 % |
| 25 | Krystal Biotech Inc | 1,818 | 469.6K $ | 1.13 % |
| 26 | Vaxcyte Inc | 8,057 | 468.2K $ | 1.12 % |
| 27 | Mirum Pharmaceuticals Inc | 5,052 | 466.7K $ | 1.12 % |
| 28 | Amicus Therapeutics Inc | 32,258 | 466.5K $ | 1.12 % |
| 29 | Travere Therapeutics Inc | 15,666 | 465.4K $ | 1.12 % |
| 30 | Ionis Pharmaceuticals Inc | 6,198 | 465.4K $ | 1.12 % |
| 31 | Arcellx Inc | 4,053 | 465.4K $ | 1.12 % |
| 32 | Regeneron Pharmaceuticals, Inc. | 598 | 462K $ | 1.11 % |
| 33 | Incyte Corp | 4,897 | 460.9K $ | 1.10 % |
| 34 | Celcuity Inc | 4,004 | 457K $ | 1.10 % |
| 35 | Revolution Medicines Inc | 4,654 | 452.6K $ | 1.08 % |
| 36 | Halozyme Therapeutics Inc | 6,973 | 450.7K $ | 1.08 % |
| 37 | Rhythm Pharmaceuticals Inc | 5,149 | 447.8K $ | 1.07 % |
| 38 | Biogen Inc | 2,434 | 446.2K $ | 1.07 % |
| 39 | Arcutis Biotherapeutics Inc | 18,809 | 443.1K $ | 1.06 % |
| 40 | AbbVie Inc | 2,036 | 442.8K $ | 1.06 % |
| 41 | Gilead Sciences Inc | 3,175 | 442.5K $ | 1.06 % |
| 42 | CRISPR Therapeutics AG | 9,284 | 441.6K $ | 1.06 % |
| 43 | BioMarin Pharmaceutical Inc | 7,685 | 434.1K $ | 1.04 % |
| 44 | Roivant Sciences Ltd | 15,671 | 434.1K $ | 1.04 % |
| 45 | Amgen Inc | 1,227 | 431.7K $ | 1.03 % |
| 46 | ImmunityBio Inc | 56,051 | 429.9K $ | 1.03 % |
| 47 | Beam Therapeutics Inc | 17,774 | 423.6K $ | 1.01 % |
| 48 | Viking Therapeutics Inc | 12,963 | 421.8K $ | 1.01 % |
| 49 | Vera Therapeutics Inc | 10,461 | 420.8K $ | 1.01 % |
| 50 | Moderna Inc | 8,282 | 420.7K $ | 1.01 % |
| 51 | Vertex Pharmaceuticals Inc | 941 | 420.2K $ | 1.01 % |
| 52 | Erasca Inc | 25,894 | 419K $ | 1.00 % |
| 53 | ACADIA Pharmaceuticals Inc | 18,671 | 415.6K $ | 1.00 % |
| 54 | Sarepta Therapeutics Inc | 16,721 | 363.8K $ | 0.87 % |
| 55 | Agios Pharmaceuticals Inc | 10,559 | 357.2K $ | 0.86 % |
| 56 | Ultragenyx Pharmaceutical Inc | 17,001 | 356.2K $ | 0.85 % |
| 57 | Disc Medicine Inc | 5,536 | 354K $ | 0.85 % |
| 58 | Immunome Inc | 16,055 | 351.1K $ | 0.84 % |
| 59 | Immunovant Inc | 14,040 | 348.8K $ | 0.84 % |
| 60 | BioCryst Pharmaceuticals Inc | 36,407 | 346.6K $ | 0.83 % |
| 61 | Veracyte Inc | 10,710 | 345K $ | 0.83 % |
| 62 | Dyne Therapeutics Inc | 18,804 | 340.9K $ | 0.82 % |
| 63 | Catalyst Pharmaceuticals Inc | 12,408 | 307.2K $ | 0.74 % |
| 64 | Syndax Pharmaceuticals Inc | 12,818 | 299.4K $ | 0.72 % |
| 65 | Denali Therapeutics Inc | 15,486 | 297.3K $ | 0.71 % |
| 66 | Ideaya Biosciences Inc | 8,909 | 296.8K $ | 0.71 % |
| 67 | Spyre Therapeutics Inc | 5,850 | 295.1K $ | 0.71 % |
| 68 | GRAIL Inc | 5,696 | 294.4K $ | 0.71 % |
| 69 | Viridian Therapeutics Inc | 14,591 | 285.4K $ | 0.68 % |
| 70 | Recursion Pharmaceuticals Inc | 91,526 | 281K $ | 0.67 % |
| 71 | Kodiak Sciences Inc | 7,348 | 280.1K $ | 0.67 % |
| 72 | Soleno Therapeutics Inc | 8,183 | 274K $ | 0.66 % |
| 73 | Dianthus Therapeutics Inc | 3,209 | 269.3K $ | 0.65 % |
| 74 | Intellia Therapeutics Inc | 20,529 | 263.2K $ | 0.63 % |
| 75 | Mineralys Therapeutics Inc | 9,697 | 262.7K $ | 0.63 % |
| 76 | Arcus Biosciences Inc | 11,832 | 255.6K $ | 0.61 % |
| 77 | Ardelyx Inc | 41,915 | 251.1K $ | 0.60 % |
| 78 | ADMA Biologics Inc | 26,895 | 242.3K $ | 0.58 % |
| 79 | Nurix Therapeutics Inc | 15,366 | 238.2K $ | 0.57 % |
| 80 | Tango Therapeutics Inc | 10,787 | 225.7K $ | 0.54 % |
| 81 | Celldex Therapeutics Inc | 6,685 | 212K $ | 0.51 % |
| 82 | Novavax Inc | 25,529 | 207.8K $ | 0.50 % |
| 83 | Oruka Therapeutics Inc | 4,161 | 204.1K $ | 0.49 % |
| 84 | Olema Pharmaceuticals Inc | 13,516 | 201.5K $ | 0.48 % |
| 85 | Stoke Therapeutics Inc | 6,156 | 200.4K $ | 0.48 % |
| 86 | Vericel Corp | 6,104 | 196.4K $ | 0.47 % |
| 87 | Capricor Therapeutics Inc | 6,408 | 194.8K $ | 0.47 % |
| 88 | Palvella Therapeutics Inc | 1,499 | 186.9K $ | 0.45 % |
| 89 | Biohaven Ltd | 21,021 | 177.8K $ | 0.43 % |
| 90 | Monte Rosa Therapeutics Inc | 10,752 | 176.9K $ | 0.42 % |
| 91 | Corvus Pharmaceuticals Inc | 11,573 | 169.3K $ | 0.41 % |
| 92 | Iovance Biotherapeutics Inc | 44,499 | 156.2K $ | 0.37 % |
| 93 | AnaptysBio Inc | 2,800 | 155.3K $ | 0.37 % |
| 94 | Relay Therapeutics Inc | 15,479 | 154K $ | 0.37 % |
| 95 | uniQure NV | 9,278 | 151.7K $ | 0.36 % |
| 96 | ORIC Pharmaceuticals Inc | 11,868 | 150.4K $ | 0.36 % |
| 97 | MannKind Corp | 59,764 | 146.4K $ | 0.35 % |
| 98 | CareDx Inc | 8,091 | 140.5K $ | 0.34 % |
| 99 | Taysha Gene Therapies Inc | 30,821 | 137.8K $ | 0.33 % |
| 100 | Tyra Biosciences Inc | 3,582 | 137.2K $ | 0.33 % |
Sector breakdown
- Health care 14.8 %
- Unattributed 85.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 95.4 %
- Ireland 1.6 %
- Switzerland 1.1 %
- Bermuda 1.1 %
- British Virgin Islands 0.4 %
- Netherlands 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 141 | 38.8M $ | 95.45 % |
| 2 | Ireland | 2 | 643.4K $ | 1.58 % |
| 3 | Switzerland | 1 | 441.6K $ | 1.09 % |
| 4 | Bermuda | 1 | 434.1K $ | 1.07 % |
| 5 | British Virgin Islands | 1 | 177.8K $ | 0.44 % |
| 6 | Netherlands | 1 | 151.7K $ | 0.37 % |
Cite this page
Titelia. "Holdings of PROFUND VP BIOTECHNOLOGY". https://titelia.com/en/funds/S000003965